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Background: Rates of chronic disease are escalating around the world. To date health service evaluations have
focused on interventions for single chronic diseases. However, evaluations of the effectiveness of new intervention
strategies that target single chronic diseases as well as multimorbidity are required, particularly in areas outside
major metropolitan centres where access to services, such as specialist care, is difficult and where the retention and
recruitment of health professionals affects service provision.
Methods: This study is a longitudinal investigation with a baseline and three follow-up assessments comparing the
health and health costs of people with chronic disease before and after intervention at a chronic disease clinic, in
regional Australia. The clinic is led by students under the supervision of health professionals. The study will provide
preliminary evidence regarding the effectiveness of the intervention, and evaluate the influence of a range of
factors on the health outcomes and costs of the patients attending the clinic. Patients will be evaluated at baseline
(intake to the service), and at 3-, 6-, and 12-months after intake to the service. Health will be measured using the
SF-36 and health costs will be measured using government and medical record sources. The intervention involves
students and health professionals from multiple professions working together to treat patients with programs that
include education and exercise therapy programs for back pain, and Healthy Lifestyle programs; as well as
individual consultations involving single professions.
Discussion: Understanding the effect of a range of factors on the health state and health costs of people
attending an interdisciplinary clinic will inform health service provision for this clinical group and will determine
which factors need to be controlled for in future observational studies. Preliminary evidence regarding changes in
health and health costs associated with the intervention will be a platform for future clinical trials of intervention
effectiveness. The results will be of interest to teams investigating new chronic disease programs particularly for
people with multimorbidity, and in areas outside major metropolitan centres.
Trial registration: Australia and New Zealand Clinical Trials Registry: ACTRN12611000724976.
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A unique student-led interdisciplinary chronic disease
health service was established in regional Australia in 2010
to address workforce shortages and spiralling rates of
chronic disease in rural and regional Queensland. The ser-
vice also aimed to improve local clinical placement options
for allied health students. The service was established in a
shopping centre with easy access using public transport.
Demographics of the people attending the service in the
first year of the service (prior to commencement of the
study) revealed very high rates of multimorbidity (97%) and
higher rates of indigenous clients (7.1%) compared with the
local community (5.9%) [1]. These demographics are rele-
vant to the expected health outcomes of people attending
the service as people with multimorbidity have worse
health outcomes [2], and place a larger burden on the
healthcare system than those with a single chronic disease.
Additionally, indigenous Australians generally have worse
health outcomes than non-indigenous Australians; includ-
ing mortality and disability rates [3].
Interdisciplinary care has been promoted as a solution
to maintain or improve the quality of healthcare, particu-
larly in regional and rural areas [4-6] where health service
disparity, healthcare access, and a worse burden of chronic
diseases may place people living in these areas at a disad-
vantage in comparison to metropolitan areas [7]. Despite
this, there are few high quality studies that evaluate the ef-
fectiveness of interdisciplinary care for chronic disease or
primary care [8], even in metropolitan areas.
This paper describes the study protocol of a longitudinal
evaluation of a unique interdisciplinary health service
established in a regional Australian city to address chronicIntake appointment
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Figure 1 The process for receiving services at the interdisciplinary clidisease. The study will estimate the health outcomes and
associated health costs of people attending the service.
Methods
Setting and services
The regional interdisciplinary chronic disease health ser-
vice is located in a regional city (Rockhampton) approxi-
mately 700 kilometres from the state’s capital. Services
are provided to people with chronic diseases in the re-
gional city and surrounding rural and remote areas (pro-
viding services to more than 100,000 residents). Referral
to the interdisciplinary clinic can arise from three
sources: self referral, referral from the local hospital or
referral from a general medical practitioner; although
the majority (90%) are referred by their general practi-
tioner [1]. Services are delivered by an interdisciplinary
team of nurses and allied health professionals, including
podiatrists, occupational therapists, exercise physiologists,
a social worker, a speech pathologist, a dietician, a physio-
therapist, a pharmacist and an indigenous health worker.
Qualified professional supervisors in allied health discip-
lines supervise up to four students each who provide a
range of services to clients with a wide range of chronic
diseases that include hypertension, osteoarthritis, high
cholesterol, diabetes, and chronic back pain. The process
for obtaining services is shown in Figure 1.
Study design
A longitudinal cohort study focusing on the health out-
comes and costs of patients with chronic diseases attending
the service will be implemented. Patients will be evaluated
at baseline (intake to the service), and at 3-, 6-, and 12- with the patient:
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follow-ups were included to evaluate short-term outcomes
after commencement of the intervention. The 12-month
follow-up was included to evaluate intermediate outcomes
to pick up a potential delay in the positive impact of inter-
vention on some dimensions of health. This study has been
prospectively registered with the Australian and New Zea-
land Clinical Trials Registry (ACTRN12611000724976).
Study objectives
Aims
1. To examine the effectiveness of the service up to
12-months post-intake in improving a range of health
outcomes (including length of stay in hospital,
number of admissions, health state, preference based
health state, and health-related costs).
2. To examine the effect of a range of factors including
comorbidities, sociodemographic factors, and type of
intervention received, on the health state, preference-
based health state, length of stay in hospital, number of
admissions, and health-related costs of people
attending the service up to 12-months post intake.
3. To determine the difference in health between
clients attending the service before and after
receiving intervention and the general population
using Australian population normative data.
Hypotheses
1. Health will be maintained or improve over time
from intake (baseline) to 12-months after intake
with a small average effect size anticipated for
improvement (effect size ≤ 0.2).
2. Health outcomes will be moderately to strongly and
negatively associated with the number of chronic
diseases (effect size ≥ 0.5).
3. Days in hospital and inpatient admission costs will
decrease after intake to the service compared with
before intake to the service.
4. The health of clients attending the service will
be worse than the general population using
Australian population normative data at all
times (effect size ≥ 0.2).
Participants and selection criteria
All clients who attended the service will be eligible to par-
ticipate. The following are inclusion criteria: presence of at
least one chronic disease; aged 18 or older; and
attendance at their first intake appointment. In addition,
clients will be required to attend a minimum of one inter-
vention session at the service for follow-up data to be in-
cluded in analyses of clinic effectiveness over time. The
following are exclusion criteria: a severe communicationdisability or behavioural disorder that would compromise
the ability to participate in the intervention program or
complete the questionnaires; a cognitive deficit that im-
pairs the ability to read and write; and known pregnancy
or up to 6-months postpartum that would influence body
mass index (BMI), waist measurements, and possibly
other outcomes. All participants receive individually tai-
lored care prescribed by the service.
Study measures
All study measures will be completed at the site of the
interdisciplinary service at baseline. However, people
who are unable to attend the clinic for a follow-up
assessment will be posted self-report questionnaires.
Questionnaires will be self-administered except in cases
where it is clear that the patient is unable to complete the
questionnaire due to an impairment (such as visual dis-
turbance) that makes self-completion difficult. In these
cases questionnaires will be interviewer-administered.
Table 1 provides a summary of each of the measures at
each time point.
Health outcomes
Health will be measured using the Australian SF-36
(Version 1). The SF-36 is a 36-item generic measure of
health with eight scales including physical functioning,
role limitations, bodily pain, social functioning, general
mental health, role limitations, vitality, and general
health perceptions [9]. Two summary scores are obtai-
ned from these scales: a physical components summary
and mental components summary. Extensive psychomet-
ric testing has occurred using people with a wide range
of chronic diseases or single chronic diseases [10-13]. A
review of studies has demonstrated that the SF-36 is
superior in terms of sensitivity to change and respon-
siveness compared to other measures of health [9]. In
addition, the SF-36 has been shown to discriminate
between types and severities of chronic diseases and to
distinguish between people with a chronic medical con-
dition only, from those with a chronic medical condition
plus a psychiatric disorder [14]. A preference-based
measure of health will be derived from the SF-36 to pro-
duce a summary health score (multi-attribute utility
score) for individuals at each time point.
Hospital utilisation will be measured using the number
of days spent in hospital and number of hospital admis-
sions during the one-year follow-up as indicators for
intervention effectiveness. This will be accessed from
hospital records for each participant.
Healthcare costs
Healthcare costs will be determined using Medicare and
hospital utilisation records. Medicare data (including
Pharmaceutical Benefits Scheme data) will be accessed
Table 1 Study outcome measures at each follow-up time
Baseline 3 months 6 months 12 months
SF-36 SF-36 SF-36 SF-36
BMI and waist measurement BMI and waist measurement BMI and waist measurement BMI and waist measurement
Comorbiditymeasure Comorbidity measure Comorbidity measure Comorbidity measure
K6
Medical Outcomes Study Social Support Survey
TUG TUG TUG TUG







Intervention data Intervention data Intervention data
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(baseline), which will permit estimation of within-patient
change in healthcare costs. This data will allow costing
of Hospital, Medicare and Pharmaceutical Benefits
Scheme related items that will include inpatient admis-
sion costs, out-of-pocket expenses for general practi-
tioners and specialist medical appointments, and out-of
-pocket medication related expenses. Clinic health pro-
fessional labour costs related to delivering the interdis-
ciplinary intervention to study participants will also be
recorded. Expenses related to alternative medications
will not be captured by these data sources.
Anthropometric measures
Height and weight measurements will be taken to allow
BMI to be calculated. A waist measurement will also be
taken as an indicator of obesity [15]. Height will be mea-
sured without shoes to the nearest 0.1 cm using a
stadiometer (Wedderburn Portable Height Rod, Model
WS-HRP). The participant will be required to stand with
their heels touching the vertical foot panel of the
stadiometer and the participant’s head held in the Frank-
fort plane. Weight will be measured in bare feet or socks
(without shoes) using a calibrated balance scale (Tanita
Digital Scales, Model HD-351) with the participant
dressed in light clothing, and any clothing pockets
emptied. Waist circumference will be measured to the
nearest 0.1 cm equidistance between the last palpable
rib and the top of the superior border of the iliac crest
with the tape perpendicular to long axis of body and
parallel to ground at the end of expiration [16,17]. The
patient will be requested to place their arms relaxed by
their side for this measurement. A narrow 7 mm wide
flexible steel anthropometrical tape measure (Rosscraft)
will be used.
Psychological distress or well-being
Psychological distress or well-being (including mood and
anxiety disorders) will be screened for using the 6-itemKessler6 (K6). A unidimensional factor structure has
been supported in a large Australian community popula-
tion [18] and the validity of the K6 has been supported
for screening serious mental illness [19] as well as for
discriminating between people with and without psycho-
logical distress in the community [20].Disease burden and number and type of comorbid
conditions
Disease burden and the number and type of comorbid
conditions will be measured using a self-report comor-
bidity measure [21]. Using the comorbidity measure [21]
25 common chronic diseases (excluding depression) are
rated for the degree to which each condition interferes
with daily activities. Scores on this measure have been
found to correlate more strongly with health state mea-
sured using the SF-36 than other comorbidity indices in
community samples [22,23].Perceived functional and structural social support
Perceived functional and structural social support will be
measured using the Medical Outcomes Study Social
Support Survey [24]. This measure was designed for re-
search with people with chronic conditions [9] and test-
ing by the authors has supported validity for use among
people with chronic diseases including support for four
social support subscales [24].Physical function
Physical function will be measured using the Timed Up
and Go Test (TUG) as an objective measure of func-
tional mobility [25]. Psychometric testing has supported
use of the TUG as a measure of functional mobility in
older adults [26-28]. Responsiveness of the TUG has
been supported in a study of geriatric patients attending
day hospital [29] and sensitivity to change has been sup-
ported among people with chronic diseases [30,31].
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Self-reported health perception will be measured using a
single question where participants rate their health on a
1 to 5 point scale as excellent to poor respectively [32].
Strong support exists for the ability of a single question
regarding self-reported health perception to reflect the
current, changing and future health status of people with
chronic disease [32].
Sociodemographic and intervention data
Demographic data collected only at baseline will include:
age, gender, indigenous status, country of birth, language
(other than English), marital status, home ownership,
highest level of education, occupation, and employment
status. Home ownership, highest level of education and oc-
cupation will be used as socioeconomic indicators. Inter-
vention data collected will include the length and type of
intervention received (for example, back school program,
gym program, diabetes education, or the professional seen).
Sample size and power
A minimum sample size of 130 participants is required
to examine the change over time from baseline to
12-months post-intake of the SF-36; using a one-group
longitudinal design, a power of 80% with a two-sided
type 1 error of 5% to detect a difference of at least
5 points in the social functioning scale of the SF-36
using a t-test [33]. Three to five points of change in
SF-36 scores has been reported as the minimally clinic-
ally important difference [33,34] and is equivalent to a
small effect size for those with chronic diseases [34]. A
small effect size is anticipated for changes in health over
12-months based on the small to large effect sizes found
in treatment effectiveness studies using the SF-36 in
related chronic disease studies over similar times
[7,12,34,35] and the high percentage of clients with mul-
tiple chronic diseases attending the service prior to the
study commencement, for whom moderate to large
effect sizes are unlikely. The sample size calculation was
based on the social functioning scale of the SF-36 as this
outcome would likely show the smallest difference and
therefore need the largest sample size. Therefore, pro-
vided the study sample size exceeds 130 participants,
this investigation should have greater than 80% power
for all outcomes.
Data analysis
Descriptive statistics and exploratory plots (boxplots or
histograms) will be used to describe the outcome vari-
ables (e.g., health state, preference based measure of
health, hospital utilisation, and costs) and potential pre-
dictors (e.g., age, employment status).
SF-36 scale raw scores will be transformed to a 0 to
100 scale. Results will be analysed using the 8 scales andthe summary scores where appropriate. Scatterplots of
the relationship between variables will be examined to
check for linearity or potentially non-linear associations.
Mean SF-36 scores will be plotted over time by demo-
graphic and disease subgroups to visually examine
chronic disease progression. Regression models will be
used to examine the effect of time and predictors on
post-intake SF-36 scores. The scores will be modelled at
3- to 12-months with the baseline score as a predictor in
order to: i) analyse the change from baseline; ii) help
control for regression to the mean [36]. Mixed models
will be used with subject-specific intercepts to model the
dependence in results over time from the same subject.
The lasso technique will be used to choose the best set
of predictor variables from an initially large set of poten-
tially important variables [37]. The residual distribution
of the best model will be examined to check that it is ap-
proximately normally distributed with no large outliers.
The count outcome variables (i.e., cost, days in hospital,
and number of hospitalisations) will be analysed using
the model described above but assuming a Poisson
distribution.
The predictors to be examined in all of the models will
be: BMI and waist measurement, disease burden, number
and type of comorbidities, self-reported health perception,
age, gender, indigenous status, country of birth, language
(other than English), marital status, home ownership,
highest level of education, occupation and employment
status, length and type of intervention; and baseline psy-
chological distress or wellbeing, functional and structural
social support, and physical function. Health (measured
using the SF-36) and the preference based measure of
health will be examined as predictors for count outcomes.
Adjustment will made for wave missing data (where a
subject misses an entire visit) using inverse probability
weighting [38]. This is a two-stage procedure. In the
first stage a logistic regression model is used to predict
which subjects are more likely to be missing at each
follow-up time. This model will include time, demo-
graphic factors and comorbidity factors collected at
baseline. The probability of each subject being missing
at each time is then calculated and inverted to create a
weight that can be used in the regression models de-
scribed above. As an example, if men at 12-months have
a 0.5 probability of responding, then the weight for men
is 2 so that the results for those men who responded at
12-months are doubled. This will enable a sensitivity
analysis with comparison to the complete case analysis
to be conducted.
The health of the study sample (using SF-36 scores)
will be compared to Australian normative data [39]
matched on select sociodemographic variables such as
age, gender and select chronic diseases using unpaired
t-tests with 95% confidence intervals.
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Each subject will provide written consent at baseline. Ethics
approval has been granted by the Central Queensland
Human Research Ethics Committee [HREC 11/QCQ/14].Discussion
This study is a broad evaluation of the client health out-
comes and healthcare costs of people attending a unique
regional service that is attempting to meet the health
needs of regional and rural Australians with chronic dis-
ease. The study will provide preliminary evidence on the
effectiveness of interdisciplinary intervention for this
clinical population; an area that has received little inves-
tigation to date [8]. In addition, it will provide evidence
regarding the influence of a range of variables including
multimorbidity on the health and health costs of people
with chronic disease in a rural and regional area. Com-
parison of the health state of people attending the
service to the general population will determine the se-
verity of health issues in the study population. The com-
bined evidence will greatly assist in informing future
service delivery and research.
The need for rigorous non-randomised studies in
community settings has been highlighted by Bettger and
Stineman [40] as these studies can identify target popu-
lations and appropriate outcomes for measurement that
are important foundations for randomised controlled
trials (or can even inform if randomised trials are re-
quired at all). Of relevance to the many participants with
multimorbidity who are likely to be recruited in this
study, randomised controlled trials to evaluate long-term
outcomes have been discussed as inappropriate for
people with conditions likely to worsen over time re-
gardless of the intervention received [40]. Thus this
longitudinal study will provide important information on
the progressive impact of chronic disease in people
in regional and rural areas who are involved in this
unique intervention program. Specifically, the study will
contribute knowledge about hospital use, health and
healthcare costs associated with chronic disease for
people in regional and rural areas over time. The factors
that influence these changes will also be investigated.
Economic and health-related outcomes from this in-
vestigation will inform other health services throughout
Australia (and elsewhere) who are considering adopting
comparable models of service delivery. Outcomes from
this study will also inform future research investigating
health service needs and clinical needs for comparable
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